ArticlePharmacoEconomics - open2026

AMPLIFY: Estimating Clinical and Humanistic Benefits of Pembrolizumab in Portugal.

Pedro Cardoso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.